The healthcare industry stands at a pivotal moment where artificial intelligence is moving beyond backโ€‘office automation toward genuine transformation of care delivery. Sarah London, CEO of Centene, highlighted this shift during a recent Fortune Most Powerful Women Summit conversation, noting that many current AI applications merely speed up billing or paperwork without addressing the underlying drivers of cost. She termed these uses โ€œinflationaryโ€ because they often enable providers to capture more revenue in a feeโ€‘forโ€‘service model rather than reducing expenses or improving outcomes. This observation challenges technology leaders to reconsider where AI investment yields the highest societal return, especially for organizations serving marginalized populations. The insight invites a strategic pivot: using AI not just to cut administrative waste but to redesign how and where care reaches patients, ultimately bending the cost curve while enhancing quality.

Centeneโ€™s scale underscores why its perspective matters. Operating Medicaid plans in 29 states alongside marketplace and Medicare Advantage offerings, the $33โ€ฏbillion enterprise serves roughly 26โ€ฏmillion membersโ€”a demographic London described as โ€œamong the poorest, sickestโ€ in their communities. These individuals frequently encounter barriers to timely care, face higher rates of chronic disease, and rely heavily on safetyโ€‘net programs. Yet historically, cuttingโ€‘edge health innovations have often bypassed this segment, leaving gaps that manifest as avoidable emergencyโ€‘room visits and preventable complications. By focusing AI efforts on populations that stand to gain the most from proactive, accessible interventions, Centene aims to turn equity concerns into a source of competitive advantage and systemic improvement, demonstrating that inclusive innovation can also be financially sound.

One of Londonโ€™s two highโ€‘impact opportunities involves moving clinical expertise into the community through AIโ€‘augmented support for frontline health workers. In rural or underserved locales where physicians are scarce, community health workers equipped with decisionโ€‘support tools can triage nonโ€‘acute symptoms, recommend appropriate selfโ€‘care, and escalate only when necessary. Such AI systems analyze symptom patterns, vital signs, and social determinants to suggest evidenceโ€‘based pathways, reducing unnecessary trips to emergency departments. Early pilots show that when workers receive realโ€‘time guidance, they manage conditions like hypertension exacerbations or minor infections with confidence, freeing clinicians to focus on complex cases. This approach not only lowers acuteโ€‘care utilization but also builds trust within neighborhoods that have historically felt alienated from the formal healthcare system.

The technical foundation for communityโ€‘based AI relies on lightweight, interoperable platforms that can operate on smartphones or tablets, even with intermittent connectivity. Natural language processing enables workers to dictate observations in vernacular speech, while machineโ€‘learning models trained on diverse datasets adjust recommendations to local prevalence rates. Integration with electronic health records, where available, ensures that any escalation carries relevant clinical history, and data collected during encounters feeds back into model refinement. Crucially, these tools are designed to augmentโ€”not replaceโ€”human judgment, preserving the essential relational element of community health work. By investing in such technologies, health plans can convert fixed labor costs into scalable preventive capacity, yielding measurable reductions in avoidable admissions and associated expenses.

The second opportunity centers on empowering patients themselves to navigate early health decisions without defaulting to a clinician visit for every concern. Interactive digital toolsโ€”ranging from symptom checkers to personalized risk calculatorsโ€”can guide individuals through a structured assessment of their condition, propose evidenceโ€‘based selfโ€‘management steps, and clarify when professional input is warranted. When patients feel equipped to interpret early signs, they are more likely to engage in timely lifestyle adjustments or medication adherence, preventing escalation. Moreover, these platforms can tailor educational content to literacy levels, language preferences, and cultural contexts, addressing the very disparities that often limit the reach of traditional health education. The result is a more informed populace that utilizes the healthcare system judiciously, reserving costly interventions for situations where they truly add value.

Effective patientโ€‘facing AI incorporates behavioral science principles to sustain engagement. Features such as goalโ€‘setting dashboards, gentle reminder nudges, and gamified progress tracking motivate ongoing participation, while builtโ€‘in feedback loops allow users to report outcomes that further refine the algorithms. Privacy and security remain paramount; leading solutions employ endโ€‘toโ€‘end encryption, transparent dataโ€‘use policies, and optโ€‘in consent mechanisms that comply with HIPAA and emerging state regulations. Importantly, these tools are not intended to supplant professional advice but to serve as a first line of triage that directs users to the appropriate level of careโ€”whether that be a telehealth consult, a pharmacy consultation, or an inโ€‘person appointment. By reducing lowโ€‘value visits, health systems can reallocate capacity toward highโ€‘need cases, improving overall access and experience.

London was quick to note that pursuing these transformative uses does not render administrative automation obsolete; rather, it sharpens the financial justification for streamlining backโ€‘office processes. Every dollar saved on claims processing, prior authorization, or eligibility verification can be redirected toward enhanced benefits, such as expanded coverage for preventive services or reduced member costโ€‘sharing. This creates a virtuous cycle: efficiency gains free up resources that fund innovative care models, which in turn generate further savings through better health outcomes. For chief financial officers, the imperative becomes clearโ€”evaluate AI investments not solely by the speed of transaction processing but by their impact on the total cost of care and the quality of outcomes delivered to the population served.

Distinguishing between merely efficient AI and economically transformative AI requires a nuanced measurement framework. The 2026 AI Adoption Report from Wharton Humanโ€‘AI Research and GBK Collective reveals that organizations tracking at least one growth metricโ€”such as member engagement, preventiveโ€‘care utilization, or reduction in readmission ratesโ€”are far more likely to report strongly positive ROI than those focusing exclusively on efficiency indicators like processing time or cost per transaction. Specifically, 35โ€ฏ% of leaders who monitor growth signals saw strong returns, compared with only 13โ€ฏ% of those who tracked efficiency alone. This disparity underscores that AIโ€™s value in healthcare is realized when it shifts utilization patterns toward healthier, more appropriate care settings rather than merely accelerating existing workflows.

Governance structures also play a decisive role in AI success. The same study found that 58โ€ฏ% of enterprises that appointed a dedicated chief AI officer reported strongly positive ROI, whereas only 8โ€ฏ% of firms lacking such leadership achieved comparable results. A chief AI officer can bridge clinical, operational, and financial perspectives, ensuring that AI initiatives align with strategic goals, adhere to regulatory standards, and are evaluated with balanced scorecards that capture both economic and health outcomes. For healthโ€‘care organizations, creating this roleโ€”or empowering an existing executive with clear AI oversightโ€”can accelerate adoption of highโ€‘impact use cases while mitigating risks associated with algorithmic bias, data quality, and change resistance.

Beyond individual organizations, the broader market context reinforces why healthcare may serve as a litmus test for AIโ€™s productivity promise. Major technology firms have pledged hundreds of billions of dollars to build the computational infrastructureโ€”cloud capacity, specialized chips, and data pipelinesโ€”underpinning nextโ€‘generation AI models. The pressing question now is whether these investments translate into tangible output gains at scale. Healthcare, with its complex workflows, stringent regulations, and substantial cost pressures, offers a clear arena to assess whether AI can deliver multiโ€‘factor productivity improvements that justify the enormous capital outlay. Success here would not only validate AIโ€™s economic potential but also pave the way for broader diffusion into other sectors.

For healthcare leaders seeking to move beyond automation, a pragmatic roadmap begins with a clear articulation of the problem they aim to solveโ€”whether it is reducing avoidable emergency visits, improving chronic disease management, or enhancing member experience. Next, they should pilot AI solutions that directly involve community health workers or patients, employing rigorous mixedโ€‘methods evaluation that captures utilization shifts, cost outcomes, and qualitative feedback. Investment in change management is essential; clinicians and frontline staff must be involved early to coโ€‘design workflows that feel supportive rather than disruptive. Finally, organizations should institute governance mechanismsโ€”such as a crossโ€‘functional AI steering committee and defined metrics that balance financial, clinical, and equity dimensionsโ€”to sustain learning and scale effective innovations.

Actionable advice for decisionโ€‘makers includes three concrete steps. First, conduct an internal audit of existing AI projects to label each as primarily efficiencyโ€‘focused or transformationโ€‘focused, then reallocate resources toward the latter category. Second, establish a partnership with a communityโ€‘based organization or a telehealth vendor to coโ€‘develop an AIโ€‘enabled triage tool tailored to the specific epidemiological profile of the member base, incorporating measurable goals such as a 10โ€ฏ% reduction in lowโ€‘acuity ER visits within twelve months. Third, appoint or empower a senior leader with explicit authority over AI strategy, charging them with delivering a quarterly dashboard that tracks both cost savings and healthโ€‘outcome indicators, ensuring that AIโ€™s impact is visible to the board and adjustable in real time. By following these steps, healthcare entities can harness AIโ€™s true potential to deliver better care at lower cost, fulfilling the promise that technology can serve both the bottom line and the communities they serve.